The Valley Desk

NCT02019264 · Interventional trial

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Overall registry status Completed

Phase 4

Conditions Cardiovascular Disease, High Cardiovascular Risk, Obesity, Overweight, Type 2 Diabetes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov